Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...
The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...
TARRYTOWN, N.Y. - A COVID-19 antibody cocktail developed by U.S. drugmaker Regeneron offered strong protection against symptomatic infection when given to people living with someone else infected with ...
The U.S. surpassed 12 million total COVID-19 cases Nov. 21, according to data from Baltimore-based Johns Hopkins University. The nation also reported more than 198,500 new cases Nov. 20, which is a ...
Oct 30 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback